ArticleJournal of cancer research and clinical oncology2004

Potent antitumoral efficacy of a novel replicative adenovirus CNHK300 targeting telomerase-positive cancer cells.

C-Q Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.